Bookmark
IMMUNOGENICITY OF SINGLE COMPARED TO TWO-DOSE PRIMARY SERIES FOLLOWED BY BOOSTER DOSE OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV) IN SOUTH AFRICA: OPEN-LABEL, RANDOMISED, NON-INFERIORITY TRIAL
(ID 1153)
Session Name
Vaccines - Pneumococcal Vaccines Development
Presenter
Shabir A. Madhi, South Africa
Authors
Shabir A. Madhi, South Africa
Eleonora Mutsaerts,
Alane Izu,
Welekazi Boyce,
Sutika Bhikha,
Benit Ikulinda,
Lisa Jose,
Anthonet Koen,
Amit Nana,
Andrew Moultrie,
Lucy Roalfe, United Kingdom
Adam Hunt,
David Goldblatt, United Kingdom
Clare L. Cutland,
Jeffrey R. Dorfman,